In-hospital initiation of statins: Taking advantage of the 'teachable moment'

Gregg C. Fonarow, MD
Director, Ahmanson-UCLA Cardiomyopathy Center; Director, Cardiology Fellowship Training Program; Co-Director, UCLA Preventive Cardiology Program; Associate Professor of Medicine, UCLA Division of Cardiology, Los Angeles

Address: Gregg C. Fonarow, MD, Ahmanson-University of California Los Angeles Cardiomyopathy Center, UCLA Division of Cardiology, 47-123 CHS, UCLA Medical Center, 10833 Le Conte Avenue, Los Angeles, CA 90095-1679; e-mail: [email protected]

The author has indicated that he has received grant or research support from the Bristol-Myers Squibb, Merck, Merck-Schering Plough, and Pfizer corporations, and that he serves as a consultant and is on the speakers’ bureaus of the same corporations.

Gregg C. Fonarow, MD
Director, Ahmanson-UCLA Cardiomyopathy Center; Director, Cardiology Fellowship Training Program; Co-Director, UCLA Preventive Cardiology Program; Associate Professor of Medicine, UCLA Division of Cardiology, Los Angeles

Address: Gregg C. Fonarow, MD, Ahmanson-University of California Los Angeles Cardiomyopathy Center, UCLA Division of Cardiology, 47-123 CHS, UCLA Medical Center, 10833 Le Conte Avenue, Los Angeles, CA 90095-1679; e-mail: [email protected]

The author has indicated that he has received grant or research support from the Bristol-Myers Squibb, Merck, Merck-Schering Plough, and Pfizer corporations, and that he serves as a consultant and is on the speakers’ bureaus of the same corporations.

Gregg C. Fonarow, MD
Director, Ahmanson-UCLA Cardiomyopathy Center; Director, Cardiology Fellowship Training Program; Co-Director, UCLA Preventive Cardiology Program; Associate Professor of Medicine, UCLA Division of Cardiology, Los Angeles

Address: Gregg C. Fonarow, MD, Ahmanson-University of California Los Angeles Cardiomyopathy Center, UCLA Division of Cardiology, 47-123 CHS, UCLA Medical Center, 10833 Le Conte Avenue, Los Angeles, CA 90095-1679; e-mail: [email protected]

The author has indicated that he has received grant or research support from the Bristol-Myers Squibb, Merck, Merck-Schering Plough, and Pfizer corporations, and that he serves as a consultant and is on the speakers’ bureaus of the same corporations.